Monitoring the treatment of hepatitis C with directly acting antivirals by serological and molecular methods.

PLoS One · 2017 · PMC5681287 · PMID 29125869

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

barely significantno p-value reported

The barely significant difference in which there was an HCV-Ag decrease between SR and RR at W8 should not, in our opinion, lead clinicians to check HCV-Ag at this time point because this time point will not represent a stopping rule and will not lead to a change in treatment.

also in 875 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.